Systematically, these findings support a model in which the EZH2/HOXA11‐AS/LSD1 complex and HOXA11‐AS/miR‐1297/EZH2 cross‐talk aid as key effectors in GC tumorigenesis as well as progression. The gene discussed is EZH2; the disease is gastric cancer.